Your browser doesn't support javascript.
loading
Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements.
Smith-Byrne, Karl; Cerani, Agustin; Guida, Florence; Zhou, Sirui; Agudo, Antonio; Aleksandrova, Krasimira; Barricarte, Aurelio; Barranco, Miguel Rodríguez; Bochers, Christoph H; Gram, Inger Torhild; Han, Jun; Amos, Christopher I; Hung, Rayjean J; Grankvist, Kjell; Nøst, Therese Haugdhal; Imaz, Liher; Chirlaque-López, María Dolores; Johansson, Mikael; Kaaks, Rudolf; Kühn, Tilman; Martin, Richard M; McKay, James D; Pala, Valeria; Robbins, Hilary A; Sandanger, Torkjel M; Schibli, David; Schulze, Matthias B; Travis, Ruth C; Vineis, Paolo; Weiderpass, Elisabete; Brennan, Paul; Johansson, Mattias; Richards, J Brent.
  • Smith-Byrne K; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Cerani A; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada/Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  • Guida F; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Zhou S; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada/Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  • Agudo A; Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia, Spain.
  • Aleksandrova K; Nutrition, Immunity and Metabolism Senior Scientist Group, Department of Nutrition and Gerontology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany.
  • Barricarte A; University of Potsdam, Institute of Nutritional Science, Potsdam, Germany.
  • Barranco MR; Navarra Institute for Health Research (IdiSNA) Pamplona, Spain.
  • Bochers CH; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Gram IT; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Han J; Escuela Andaluza de Salud Pública (EASP), Granada, Spain.
  • Amos CI; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
  • Hung RJ; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada/Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  • Grankvist K; University of Victoria-Genome British Columbia Proteomics Centre, Victoria, BC, Canada/Division of Medical Sciences, University of Victoria, Victoria, British Columbia, Canada.
  • Nøst TH; Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Norway.
  • Imaz L; University of Victoria-Genome British Columbia Proteomics Centre, Victoria, BC, Canada/Division of Medical Sciences, University of Victoria, Victoria, British Columbia, Canada.
  • Chirlaque-López MD; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Johansson M; Prosserman Centre for Health Research, Mount Sinai Hospital, Toronto, Canada.
  • Kaaks R; Department of Medical Biosciences, Umeå University, Umeå, Sweden.
  • Kühn T; Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Norway.
  • Martin RM; Ministry of Health of the Basque Government, Public Health Division of Gipuzkoa, Donostia-San Sebastian, Spain.
  • McKay JD; Biodonostia Health Research Institute, Donostia-San Sebastian, Spain.
  • Pala V; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Robbins HA; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain.
  • Sandanger TM; Department of Radiation Sciences, Umeå University, Umeå, Sweden.
  • Schibli D; German Cancer Research Center (DKFZ), Heidelberg, Department of Cancer Epidemiology.
  • Schulze MB; Translational Lung Research Center (TLRC) Heidelberg, Member of the German Center for Lung Research (DZL), Germany.
  • Travis RC; German Cancer Research Center (DKFZ), Heidelberg, Department of Cancer Epidemiology.
  • Vineis P; Clinical Epidemiology & Public Health, University of Bristol, Bristol, United Kingdom.
  • Weiderpass E; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Brennan P; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano.
  • Johansson M; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Richards JB; Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Norway.
Cancer Epidemiol Biomarkers Prev ; 31(10): 1966-1974, 2022 10 04.
Article en En | MEDLINE | ID: mdl-35839461
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Análisis de la Aleatorización Mendeliana / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Análisis de la Aleatorización Mendeliana / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article